MedPath

Follow-up Visit of High Risk Infants

Recruiting
Conditions
Infant, Premature
Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Registration Number
NCT00009633
Lead Sponsor
NICHD Neonatal Research Network
Brief Summary

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.

Detailed Description

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort study in which surviving extremely low birth-weight infants undergo neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 month corrected age). The goal of the study is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment, including:

* Evaluating development of motor skills, cognitive skills, language and behavior

* Determining mortality and the prevalence of specific medical conditions

* Assessing the relationship between growth and neurodevelopmental outcome

* Assessing the relationship between the socioeconomic status and developmental outcome

* Assessing the use of special support services and early intervention programs by this population

* Evaluating the need for follow-up at school age.

The scheduled evaluations collect: demographic information; socioeconomic status; medical history; medications; medical equipment required; growth data; a detailed neurologic examination; Bayley Scales of Infant Development (mental, motor, infant behavior); Child Behavior Checklist.

A sub-study will assess a reference group comprised of a limited number of healthy term infants born in Network centers to meet the following three aims: 1) to avoid potential ascertainment biases due to examiner expectations when only extremely preterm or other high-risk infants are assessed 2) in the absence of well-developed norms for the Bayley Scales, to define thresholds for impairment based on data for a representative sample of healthy children born at term in our centers and concurrently assessed by the same examiners as for our high-risk infants; and 3) to help identify and address when "drift" occurs over time in conducting and scoring Bayley assessments.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
68000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To maintain a registry of baseline and outcome data for VLBW infants with data collected in a uniform mannerLongitudinal database currently funded through 3/31/2016
Secondary Outcome Measures
NameTimeMethod
To provide data for hypothesis formulation and sample size calculation for Network multi-center studiesLongitudinal database currently funded through 3/31/2016
To examine the relationship between baseline characteristics and outcomeLongitudinal database currently funded through 3/31/2016

Trial Locations

Locations (31)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of California - Los Angeles

🇺🇸

Los Angeles, California, United States

Stanford University

🇺🇸

Palo Alto, California, United States

University of California at San Diego

🇺🇸

San Diego, California, United States

Sharp Mary Birch Hospital for Women & Newborns

🇺🇸

San Diego, California, United States

Yale University

🇺🇸

New Haven, Connecticut, United States

George Washington University

🇺🇸

Washington, District of Columbia, United States

University of Miami

🇺🇸

Miami, Florida, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Northwestern Lurie Children's Hospital of Chicago

🇺🇸

Chicago, Illinois, United States

Scroll for more (21 remaining)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Waldemar A. Carlo, MD
Principal Investigator
Myriam Peralta-Carcelen, MD MPH
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.